Supriya Lifescience Key Ratios
NSE: SUPRIYA | BSE: 543434
₹889.25
₹-26.10
(-2.85%)
As on 07-Oct-2026IST
Market cap
₹7,165 Cr
Revenue (TTM)
₹873 Cr
P/E Ratio
36.1
P/B Ratio
5.9
Div. Yield
0.1 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -31.38 | 30.79 | 28.14 | 21.08 | 16.17 |
| EBIT | -56.78 | -14.88 | 13.70 | 26.06 | 9.88 |
| Net Profit | -67.61 | -30.89 | 11.57 | 28.74 | 11.09 |
| EPS | -67.61 | -30.89 | 11.38 | 28.67 | 9.00 |
| Book Value | -- | -- | 20.16 | 19.64 | 32.31 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 31.58 | 31.70 | 29.67 | 32.19 | 34.53 |
| Net Margin
| 24.01 | 23.87 | 22.44 | 24.91 | 26.61 |
| Return on equity
| 18.51 | 20.71 | 17.43 | 19.06 | 20.74 |
| Return on Capital
| 25.08 | 27.46 | -- | 25.30 | 27.62 |
| Return on Assets
| 16.33 | 17.25 | 16.07 | 16.90 | 18.42 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
25.30
|
27.62
|
22.31
|
18.71
|
43.34
|
|
|
|
|
|
|
Peer Median
|
--
|
21.34
|
21.76
|
21.89
|
--
|
17.36
|
|
|
|
|
|
ROE
17.43
Higher than Peers by 1.98
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
17.43
|
19.06
|
20.74
|
15.73
|
13.66
|
34.34
|
|
|
|
|
|
|
Peer Median
|
15.45
|
18.24
|
17.93
|
16.42
|
--
|
17.35
|
|
|
|
|
|
ROA
16.07
Higher than Peers by 5.51
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
16.07
|
16.90
|
18.42
|
13.66
|
11.56
|
25.73
|
|
|
|
|
|
|
Peer Median
|
10.55
|
10.51
|
12.81
|
12.32
|
--
|
10.65
|
|
|
|
|
|
EBIT Margin
29.67
Higher than Peers by 12.02
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
29.67
|
32.19
|
34.53
|
28.03
|
25.30
|
38.46
|
|
|
|
|
|
|
Peer Median
|
17.65
|
18.18
|
18.93
|
21.05
|
--
|
11.27
|
|
|
|
|
|
Net Margin
22.44
Higher than Peers by 8.49
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
22.44
|
24.91
|
26.61
|
20.49
|
19.08
|
28.24
|
|
|
|
|
|
|
Peer Median
|
13.95
|
13.32
|
14.94
|
15.51
|
--
|
11.45
|
|
|
|
|
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
25.97
|
26.65
|
20.86
|
19.69
|
27.51
|
|
|
|
|
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Revenue Growth
28.14
Higher than Peers by 16.21
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
28.14
|
18.86
|
22.12
|
23.73
|
-13.04
|
35.49
|
|
|
|
|
|
|
Peer Median
|
11.93
|
11.99
|
10.90
|
13.44
|
--
|
11.49
|
|
|
|
|
|
EBIT Growth
13.70
Lower than Peers by 8.26
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
13.70
|
10.83
|
50.41
|
37.09
|
-42.79
|
22.53
|
|
|
|
|
|
|
Peer Median
|
21.96
|
15.05
|
15.01
|
23.50
|
--
|
-1.10
|
|
|
|
|
|
Net Profit Growth
11.57
Lower than Peers by 11.99
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
11.57
|
11.26
|
57.80
|
32.56
|
-40.81
|
22.83
|
|
|
|
|
|
|
Peer Median
|
23.56
|
11.28
|
14.80
|
30.12
|
--
|
4.90
|
|
|
|
|
|
EPS Growth
11.38
Lower than Peers by 8.30
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
11.38
|
11.26
|
57.80
|
32.56
|
-40.81
|
11.69
|
|
|
|
|
|
|
Peer Median
|
19.69
|
12.16
|
14.27
|
29.02
|
--
|
10.00
|
|
|
|
|
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
20.16
|
22.25
|
16.57
|
13.61
|
129.24
|
|
|
|
|
|
|
Peer Median
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
--
|
--
|
--
|
0.02
|
0.03
|
|
|
|
|
|
|
Peer Median
|
0.01
|
0.05
|
0.06
|
0.03
|
--
|
0.18
|
|
|
|
|
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
--
|
--
|
--
|
0.02
|
0.03
|
|
|
|
|
|
|
Peer Median
|
Current Ratio
4.40
Higher than Peers by 2.38
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
4.40
|
4.40
|
5.07
|
5.03
|
4.85
|
4.99
|
|
|
|
|
|
|
Peer Median
|
2.02
|
1.93
|
1.90
|
2.23
|
--
|
1.72
|
|
|
|
|
|
Quick Ratio
3.08
Higher than Peers by 1.59
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
3.08
|
3.08
|
3.71
|
3.96
|
3.65
|
4.06
|
|
|
|
|
|
|
Peer Median
|
1.49
|
1.52
|
1.46
|
1.59
|
--
|
1.41
|
|
|
|
|
|
Interest Coverage
154.15
Higher than Peers by 135.12
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
154.15
|
100.13
|
138.28
|
33.18
|
41.04
|
50.37
|
|
|
|
|
|
|
Peer Median
|
19.02
|
19.95
|
24.96
|
45.29
|
--
|
24.64
|
|
|
|
|
|
Operating Efficiency
Debtors to sales
25.15
Higher than Peers by 3.99
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
25.15
|
26.51
|
19.29
|
19.58
|
18.37
|
21.73
|
|
|
|
|
|
|
Peer Median
|
21.16
|
19.87
|
21.77
|
20.10
|
--
|
23.77
|
|
|
|
|
|
Asset Turnover
0.71
Lower than Peers by 0.02
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
0.71
|
0.74
|
0.77
|
0.74
|
0.66
|
1.00
|
|
|
|
|
|
|
Peer Median
|
0.73
|
0.78
|
0.76
|
0.81
|
--
|
1.05
|
|
|
|
|
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
70.59
|
57.43
|
55.39
|
70.62
|
58.51
|
|
|
|
|
|
|
Peer Median
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
55.45
|
47.52
|
56.71
|
73.53
|
51.10
|
|
|
|
|
|
|
Peer Median
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
133.19
|
115.90
|
101.89
|
114.26
|
93.20
|
|
|
|
|
|
|
Peer Median
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
--
|
-7.15
|
-10.96
|
10.21
|
29.89
|
16.41
|
|
|
|
|
|
|
Peer Median
|
Valuation
Price / Earnings
36.12
Higher than Peers by 4.25
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
36.12
|
21.75
|
31.41
|
22.42
|
17.08
|
26.13
|
|
|
|
|
|
|
Peer Median
|
31.87
|
33.00
|
26.81
|
39.85
|
--
|
26.65
|
|
|
|
|
|
Price / Book Value
5.86
Higher than Peers by 0.92
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
5.86
|
3.80
|
5.92
|
3.27
|
2.19
|
6.44
|
|
|
|
|
|
|
Peer Median
|
4.95
|
5.41
|
4.65
|
6.11
|
--
|
3.55
|
|
|
|
|
|
Dividend Yield
0.11
Lower than Peers by 0.46
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
0.11
|
0.18
|
0.14
|
0.24
|
0.31
|
0.12
|
|
|
|
|
|
|
Peer Median
|
0.58
|
0.59
|
0.61
|
0.37
|
--
|
0.04
|
|
|
|
|
|
EV/EBITDA
23.52
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
23.52
|
14.59
|
21.51
|
13.90
|
10.07
|
16.97
|
|
|
|
|
|
|
Peer Median
|
--
|
27.20
|
27.02
|
34.57
|
--
|
17.31
|
|
|
|
|
|
Market Cap
7,165
Lower than Peers by 10,292
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
|
7,165
|
4,548
|
5,904
|
2,670
|
1,535
|
3,967
|
|
|
|
|
|
|
Peer Median
|
17,456
|
15,354
|
20,914
|
25,297
|
--
|
474
|
|
|
|
|
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
